Table 3.
Adverse events (AEs) and serious adverse events (SAEs)
| 
AEs
 | 
P † | 
SAEs
 | 
P † | |||
|---|---|---|---|---|---|---|
| Case (n = 10) | Control (n = 10) | Case (n = 10) | Control (n = 10) | |||
| Gait disturbance | 3 | 5 | 0.65 | |||
| Dysphagia | 4 | 2 | 0.62 | |||
| Muscular weakness | 7 | 8 | > 0.99 | 1 | 0 | > 0.99 | 
| Constipation | 3 | 0 | 0.21 | |||
| Myalgia | 2 | 5 | 0.35 | |||
| Anemia | 1 | 0 | > 0.99 | |||
| Hyperglycemia | 0 | 2 | 0.47 | |||
| Total | 20 | 22 | 1 | 0 | ||
AE: Adverse event; SAE: Serious adverse event
All P-values were calculated by chi-square test